These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26563630)

  • 21. Stakeholders' perspectives on quality indicators for diabetes care: a qualitative study.
    Markhorst J; Martirosyan L; Calsbeek H; Braspenning J
    Qual Prim Care; 2012; 20(4):253-61. PubMed ID: 23113910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of rapid guidelines: 2. A qualitative study with WHO guideline developers.
    Florez ID; Morgan RL; Falavigna M; Kowalski SC; Zhang Y; Etxeandia-Ikobaltzeta I; Santesso N; Wiercioch W; Schünemann HJ
    Health Res Policy Syst; 2018 Jul; 16(1):62. PubMed ID: 30005710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrating public preferences into national reimbursement decisions: a descriptive comparison of approaches in Belgium and New Zealand.
    Leopold C; Lu CY; Wagner AK
    BMC Health Serv Res; 2020 Apr; 20(1):351. PubMed ID: 32334579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prescription medicines: decision-making preferences of patients who receive different levels of public subsidy.
    Robertson J; Doran E; Henry DA; Salkeld G
    Health Expect; 2014 Feb; 17(1):15-26. PubMed ID: 21838831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stakeholder involvement: how to do it right: article 9 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.
    Cluzeau F; Wedzicha JA; Kelson M; Corn J; Kunz R; Walsh J; Schünemann HJ;
    Proc Am Thorac Soc; 2012 Dec; 9(5):269-73. PubMed ID: 23256170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical practice guidelines' development and use in New Zealand: an evolving process.
    McKinlay E; McLeod D; Dowell A; Marshall C
    N Z Med J; 2004 Aug; 117(1199):U999. PubMed ID: 15475982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spine update. Patient preferences and the development of practice guidelines.
    Owens DK
    Spine (Phila Pa 1976); 1998 May; 23(9):1073-9. PubMed ID: 9589550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient preferences versus physicians' judgement: does it make a difference in healthcare decision making?
    Mühlbacher AC; Juhnke C
    Appl Health Econ Health Policy; 2013 Jun; 11(3):163-80. PubMed ID: 23529716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Why consider patients' preferences? A discourse analysis of clinical practice guideline developers.
    Boivin A; Green J; van der Meulen J; Légaré F; Nolte E
    Med Care; 2009 Aug; 47(8):908-15. PubMed ID: 19543120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A structured tool to analyse coverage decisions: development and feasibility test in the field of cancer screening and prevention.
    Fischer KE; Leidl R; Rogowski WH
    Health Policy; 2011 Aug; 101(3):290-9. PubMed ID: 21529980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using real-world data for coverage and payment decisions: the ISPOR Real-World Data Task Force report.
    Garrison LP; Neumann PJ; Erickson P; Marshall D; Mullins CD
    Value Health; 2007; 10(5):326-35. PubMed ID: 17888097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, Conduct, and Use of Patient Preference Studies in the Medical Product Life Cycle: A Multi-Method Study.
    van Overbeeke E; Janssens R; Whichello C; Schölin Bywall K; Sharpe J; Nikolenko N; Phillips BS; Guiddi P; Pravettoni G; Vergani L; Marton G; Cleemput I; Simoens S; Kübler J; Juhaeri J; Levitan B; de Bekker-Grob EW; Veldwijk J; Huys I
    Front Pharmacol; 2019; 10():1395. PubMed ID: 31849657
    [No Abstract]   [Full Text] [Related]  

  • 34. PATIENT-CENTERED DECISION MAKING: LESSONS FROM MULTI-CRITERIA DECISION ANALYSIS FOR QUANTIFYING PATIENT PREFERENCES.
    Marsh K; Caro JJ; Zaiser E; Heywood J; Hamed A
    Int J Technol Assess Health Care; 2018 Jan; 34(1):105-110. PubMed ID: 29277175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A generic tool for development of decision aids based on clinical practice guidelines.
    Raats CJ; van Veenendaal H; Versluijs MM; Burgers JS
    Patient Educ Couns; 2008 Dec; 73(3):413-7. PubMed ID: 18768285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Managed competition in the Netherlands-a qualitative study.
    Heinemann S; Leiber S; Gress S
    Health Policy; 2013 Feb; 109(2):113-21. PubMed ID: 23031431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How well do guidelines incorporate evidence on patient preferences?
    Chong CA; Chen IJ; Naglie G; Krahn MD
    J Gen Intern Med; 2009 Aug; 24(8):977-82. PubMed ID: 19387746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contextual factors influencing research use in nursing.
    French B
    Worldviews Evid Based Nurs; 2005; 2(4):172-83. PubMed ID: 17040525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How do guideline developers identify, incorporate and report patient preferences? An international cross-sectional survey.
    Blackwood J; Armstrong MJ; Schaefer C; Graham ID; Knaapen L; Straus SE; Urquhart R; Gagliardi AR
    BMC Health Serv Res; 2020 May; 20(1):458. PubMed ID: 32448198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are we entering a new era for qualitative research? Using qualitative evidence to support guidance and guideline development by the World Health Organization.
    Lewin S; Glenton C
    Int J Equity Health; 2018 Sep; 17(1):126. PubMed ID: 30244675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.